Laser treatment for toenail fungus

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7161, Issue , 2009, Pages

  Harris, David M ^a,b   McDowell, Brian A ^c   Strisower, John ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PathoLase Inc   (United States)

^c Northern California Orthopedic Centers   (United States)

Author keywords

Laser; Onychomycosis; Toenail fungus

Indexed keywords

ADVERSE EFFECT; LASER TREATMENT; ONYCHOMYCOSIS; PULSED LASER; TOENAIL FUNGUS;

LASERS; LIGANDS;

PULSED LASER APPLICATIONS;

EID: 66249090884     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.810193     Document Type: Conference Paper

References (15)

1. Elewski, B.E., Charif, M.A. "Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions", Arch Dermatol 133, 1172-1173 (1977).
2. Elewski, B.E., Hay RJ. "Update on the management of onychomycosis: highlights of the Third Annual International Summit on Cutaneous Antifungal Therapy", Clin Infect Dis 23, 305-313 (1996).
3. Clayton, Y.M., "Clinical and mycological diagnostic aspects of onychomycosis and dermatomycoses", Clin Exp Dermatol 17(1), 37-40 (1992).
4. Ghannoum, M.A., Hajjeh RA, Scher R et al., "A large-scale North American study of fungal isolates from nails: the frequency of onychomycosis, fungal distribution, and antifungal susceptibility patterns", J Am Acad Dermatol 43, 641-648 (2000).
5. Crawford, F., Young P., Godfrey C et al., "Oral treatments for toenail onychomycosis: a systematic review", Arch Dermatol 138, 811-816 (2002).
6. Elewski, B.E., "A full 'cure' for onychomycosis is not always possible", Arch Dermatol 135, 852-853 (1999).
7. Elewski, B.E., "Onychomycosis: pathogenesis, diagnosis, and management", Clin Microbiol Rev 11, 415-429 (1998).
8. Gupta, A.K., "Ciclopirox nail lacquer: a brush with onychomycosis", Cutis 68, 13-16 (2001).
9. Finch, J.J., Warshaw E.M., "Toenail onychomycosis: current and future treatment options", Dermatol Ther 20, 31-46 (2007).
10. Arrese, J.E., Pierard G.E., "Treatment failures and relapses in onychomycosis: a stubborn clinical problem", Dermatology 207, 255-260 (2003).
11. Katz, H.I., "Drug interactions of the newer oral antifungal agents", Br J Dermatol 141 (Suppl. 56), 26-32 (1999).
12. Grover, C., Bansal S., Nanda S. et al., "Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial", Br J Dermatol 157, 364-368 (2007).
13. Conant, M., "New treatment options for onychomycosis", AIDS Patient Care 9 (Suppl. 1), S19-S21 (1991).
14. Lecha, M., Effendy I., Feuilhade de Chauvin M., Di Chiacchio N., Baran R., "Treatment options-development of consensus guidelines. Taskforce on Onychomycosis Education" J Eur Acad Dermatol Venereol Suppl 1, 25-33 (2005).
15. Scher, R.K., Baran, R., "Onychomycosis in clinical practice: factors contributing to recurrence", Br J Dermatol 149 (Suppl 65), 5-9 (2003).